HY-13428-5mg
|
MedChemexpress LLC
|
Tubacin [CAS 537049-40-4]
|
|
Cancer-programmed cell death
|
|
HY-13428-1mL
|
MedChemexpress LLC
|
Tubacin [CAS 537049-40-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
ATGP2056-10ug
|
NKMax Bio (ATGen)
|
mutY [1-350 a.a.], Recombinant Protein
|
E.coli
|
SDS-PAGE
|
|
ATGP2056-50ug
|
NKMax Bio (ATGen)
|
mutY [1-350 a.a.], Recombinant Protein
|
E.coli
|
SDS-PAGE
|
|
ATGP2465-100ug
|
NKMax Bio (ATGen)
|
RAD51B [1-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
ATGP2465-500ug
|
NKMax Bio (ATGen)
|
RAD51B [1-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
GTX100212
|
GeneTex International Corporation
|
CENPF [C3], C-term, Rabbit Polyclonal Antibody
|
Human, Zebrafish
|
ICC/IF, IHC-P, WB, IHC-Wm
|
|
GTX100212-S
|
GeneTex International Corporation
|
CENPF [C3], C-term, Rabbit Polyclonal Antibody
|
Human, Zebrafish
|
ICC/IF, IHC-P, WB, IHC-Wm
|
|
228-12801-2
|
RayBiotech, Inc.
|
GRB2-Related Adaptor Protein 2, Human Recombinant
|
|
|
|
HY-138831-10mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
HY-138831-100mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
HY-138831-25mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
HY-138831-5mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
HY-138831-50mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
HY-10237-10mg
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0]
|
|
COVID-19-anti-virus
|
|
HY-10237-100mg
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0]
|
|
COVID-19-anti-virus
|
|
HY-10237-200mg
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0]
|
|
COVID-19-anti-virus
|
|
HY-10237-5mg
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0]
|
|
COVID-19-anti-virus
|
|
HY-10237-50mg
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0]
|
|
COVID-19-anti-virus
|
|
HY-10237-1mL
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
HY-124828-10mg
|
MedChemexpress LLC
|
CMLD-2 [CAS 958843-91-9]
|
|
Cancer-programmed cell death
|
|
HY-124828-5mg
|
MedChemexpress LLC
|
CMLD-2 [CAS 958843-91-9]
|
|
Cancer-programmed cell death
|
|
HY-124828-1mL
|
MedChemexpress LLC
|
CMLD-2 [CAS 958843-91-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-R03078-20nmol
|
MedChemexpress LLC
|
mMu -miR-350-3p mimic
|
|
Cancer-programmed cell death
|
|
HY-R03078-5nmol
|
MedChemexpress LLC
|
mMu -miR-350-3p mimic
|
|
Cancer-programmed cell death
|
|